Singapore Institute of Advanced Medicine Holdings Ltd. (SGX:9G2)

Singapore flag Singapore · Delayed Price · Currency is SGD
0.0290
-0.0020 (-6.45%)
At close: Aug 8, 2025
-6.45%
Market Cap30.39M
Revenue (ttm)16.14M
Net Income (ttm)-28.87M
Shares Out1.05B
EPS (ttm)-0.03
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume550,000
Average Volume469,515
Open0.0300
Previous Close0.0310
Day's Range0.0290 - 0.0300
52-Week Range0.0260 - 0.0900
Betan/a
RSI46.19
Earnings DateOct 29, 2025

About Theseus Pharmaceuticals

Singapore Institute of Advanced Medicine Holdings Ltd., an investment holding company, provides medical diagnostics and treatments, and radiation therapy and medical oncology services in Singapore. The company offers medical diagnostics and treatments, including cancer-related diagnostics and theranostics treatments, general diagnostics and health screening, and aesthetic services; and radiation therapy and medical oncology services comprise proton beam therapy, photon radiation therapy, and medical oncology services. It provides clinic and ima... [Read more]

Industry Medical Laboratories
Founded 2011
Country Singapore
Stock Exchange Singapore Exchange - Catalist
Ticker Symbol 9G2
Full Company Profile

Financial Performance

In 2024, SGXC:9G2's revenue was 16.65 million, an increase of 2.54% compared to the previous year's 16.23 million. Losses were -37.45 million, 107.2% more than in 2023.

Financial Statements

News

There is no news available yet.